Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023

Appendices

Appendix: Speaker Biographies

Tobias Dreischulte, MPharm, MSc, PhD, is Professor of Clinical Health Services Research at the Department of General Practice and Family Medicine at University Hospital of the Ludwig Maximilian University of Munich. In addition to using large electronic databases to characterize the risks of ambulatory therapeutics, including novel approaches to identify adverse drug events, his work focuses on the design, conduct and evaluation of complex interventions to improve prescribing safety in primary care.

G. Caleb Alexander, MD, MS, is a Visiting Professor at Ludwig Maximilian University of Munich and a Professor of Epidemiology and Medicine at Johns Hopkins Bloomberg School of Public Health, where he serves as a founding co-Director of the Center for Drug Safety and Effectiveness and Principal Investigator of the Johns Hopkins Center of Excellence in Regulatory Science and Innovation (CERSI). He is a practicing general internist and pharmacoepidemiologist and is internationally recognized for his research examining prescription drug utilization, safety, and effectiveness.

Daniel Budnitz, MD, MPH, is currently a Global Medical Safety Officer with Kenvue, where he is responsible for the safety of cough and cold products. Previously, he served in the US Public Health Service, including as the founding Director of the Medication Safety Program at the US Centers for Disease Control and Prevention (CDC), where he designed and implemented a national adverse drug event surveillance system.

Carmel Hughes, PhD, is Professor of Primary Care at the School of Pharmacy, Queen’s University Belfast. She was the first pharmacist to have been appointed to a Harkness Fellowship in Healthcare Policy, the only pharmacist to receive a Primary Care Career Scientist Award and a former Cochrane Fellow. Her research interests center on prescribing in older people, intervention development, and evidence-based healthcare.

Renke Maas, MD, is a physician and board-certified specialist in Clinical Pharmacology and a Professor of Clinical Pharmacology and Drug Therapy Safety at the Friedrich-Alexander-University Erlangen-Nürnberg. His work focuses on the identification and characterization of risk markers and the detection and prevention of adverse drug reactions and medication errors.

Alpana Mair, PhD, is responsible for coordinating delivery of the Government’s work program, and advising Ministers on quality, prescribing, safety and effective use of medicines. She is the principle investigator and coordinator of the EU-funded projects iSIMPATHY and SIMPATHY, and is responsible for the development of Scottish National Polypharmacy guidance, as well as quality prescribing guidelines, patient app and shared decision-making tools.

Emily G. McDonald, MD, MSc, FRCPC, is an Associate Professor of Medicine and subspecialist in General Internal Medicine at McGill University. She is the Associate Chair of Quality and Safety for the Department of Medicine and the Scientific Director of the Canadian Medication Appropriateness and Deprescribing Network.

Andreas D. Meid, PhD, is head of the Pharmacoepidemiology Section in the Department of Clinical Pharmacology and Pharmacoepidemiology at Heidelberg University Hospital. His research interests include examining pharmacoepidemiologic databases to determine individualized treatment recommendations.

Rupert Payne, PhD, FRCPE, MRCGP, FBPhS, is Professor of Primary Care and Clinical Pharmacology at the University of Exeter, UK. He is based in the Exeter Collaboration for Academic Primary Care and leads a program of research around medication optimization, with a particular focus on polypharmacy, and has particular expertise in the use of routine electronic health records.

Sebastian Schneeweiss, MD, ScD, is a Professor of Medicine at Harvard Medical School and Chief of the Division of Pharmacoepidemiology in the Department of Medicine, Brigham and Women’s Hospital, Boston. His research focuses on assessing the effectiveness and safety of biopharmaceuticals in clinical practice.

Hanna M. Seidling, PhD, is head of the Cooperation Unit Clinical Pharmacy at the University Hospital Heidelberg. As a pharmacist specialized in drug information, her research interests include the development, implementation and evaluation of strategies to improve medication safety.

Saad Shakir, MB, ChB, LRCP&S, FRCP, FFPM, MRCGP, is Director of the Drug Safety Research Unit (DSRU) in Southampton, an academic Unit associated with the University of Portsmouth. Here he leads a research team with an active program for monitoring and studying the safety of medicines

Samy Suissa, PhD, FRSC, FCAHS, is a Distinguished James McGill Professor of Epidemiology and Biostatistics and Medicine at McGill University, and the Director of the Centre for Clinical Epidemiology, Lady Davis Institute of the Jewish General Hospital, Montreal, Canada. He established the McGill Pharmacoepidemiology Research Unit and was the founding Director of the Quebec Research Network on Medication Use, funded by the FRSQ.

Cara Tannenbaum, MD, MSc, is the co-founder and inaugural scientific director of the Canadian Deprescribing Network. She is a Professor of Medicine and practicing geriatrician at the Université de Montréal, where she held the Michel Saucier Endowed Chair in Geriatric Pharmacology, Health and Aging from 2008 to 2022.

Participants

Tobias Dreischulte – Organizer

Professor of Clinical Health Services and Research

Ludwig Maximilian University of Munich, Munich, Germany

G. Caleb Alexander – Organizer

Professor of Epidemiology and Medicine

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

Sebastian Schneeweiss – Keynote

Professor of Medicine

Harvard, Cambridge, MA, USA

Darren Ashcroft

Professor of Pharmacoepidemiology

University of Manchester, Manchester, UK

Vita Brisnik

Pharmacist Doctoral Student

Ludwig Maximilian University of Munich, Munich, Germany

Daniel Budnitz – Speaker

Global Medical Safety Officer

Kenvue, Fort Washington, PA, USA

Marieke De Bruin

Professor of Drug Policy and Regulation

Utrecht University, Utrecht, The Netherlands

Petra Denig

Professor of Drug Utilization Quality

University of Groningen, Groningen, The Netherlands

Stefan Endres

Director of Clinical Pharmacology

Ludwig Maximilian University of Munich, Munich, Germany

Daniela Fialová

Associate Professor at the Department of Social and Clinical Pharmacy

Charles University, Prague, Czech Republic

Ronja Flemming

Chair of Health Economics

Technical University of Munich, Munich, Germany

Martin Fromm

Chair of Clinical Pharmacology and Clinical Toxicology

Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

Helga Gardarsdottir

Associate Professor at Division of Pharmacoepidemiology and Clinical Pharmacology

Utrecht University, Utrecht, The Netherlands

Jochen Gensichen

Director, Professor of General Medicine

Ludwig Maximilian University of Munich, Munich, Germany

Tobias Gerhard

Director, Center for Pharmacoepidemiology and Treatment Science

Rutgers University, New Brunswick, NJ, USA

Eva Grill

Professor of Epidemiology

Ludwig Maximilian University of Munich, Munich, Germany

Larus Steinþór Guðmundsson

Associate Professor of Pharmaceutical Science

University of Iceland, Reykjavik, Iceland

Christine Hallgreen

Associate Professor at Copenhagen Centre for Regulatory Science

University of Copenhagen, Copenhagen, Denmark

Annette Härdtlein

Pharmacist

Ludwig Maximilian University of Munich, Munich, Germany

Carmel Hughes – Speaker

Professor of Primary Care Pharmacy

Queens University, Belfast, Northern Ireland

Ulrich Jaehde

Professor of Clinical Pharmacy

University of Bonn, Bonn, Germany

Kristina Johnell

Professor in Geriatric Pharmacoepidemiology

Karolinska Institute, Solna, Sweden

Thomas Kühlein

Chair of General Medicine

Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

Renke Maas – Speaker

Professor of Drug Therapy Safety and Clinical Pharmacology

Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

Alpana Mair – Speaker

Head of Effective Prescribing and Therapeutics

The Scottish Government, Edinburgh, UK

Emily McDonald – Speaker

Associate Professor of Medicine

McGill University, Montreal, QC, Canada

Andreas Meid – Speaker

Post-Doctoral Researcher in Clinical Pharmacology and Pharmacoepidemiology

University of Heidelberg, Heidelberg, Germany

Eva-Lisa Meldau

Data Scientist

Uppsala Monitoring Centre, Uppsala, Sweden

Achim Mortsiefer

Chair of General and Family Medicine

Universität Witten Herdecke, Witten, Germany

Christiane Muth

Head of General and Family Medicine

University of Bielefeld, Bielefeld, Germany

Rupert Payne – Speaker

Professor of Primary Care and Clinical Pharmacology

University of Exeter, Exeter, UK

Cristin Ryan

Professor in Pharmacy Practice

Trinity College Dublin, Dublin, Ireland

Andre Said

Head of the Office of the Drug Commission of German Pharmacists

ABDA – Federal Union of German Associations of Pharmacists, Berlin, Germany

Miriam Schechner

Pharmacist

Ludwig Maximilian University of Munich, Munich, Germany

Sven Schmiedl

Professor of Clinical Studies and Regulatory Aspects

University of Witten/Herdecke, Witten, Germany

Oliver Schwalbe

Managing Director

The Scientific Institute of the Westphalia-Lippe Chamber of Pharmacists for Health Research in Pharmacies, Münster, Germany

Hanna Seidling – Speaker

Head of Cooperation Unit Clinical Pharmacy

University of Heidelberg, Heidelberg, Germany

Faiza Shahid

Pharmacist

Ludwig Maximilian University of Munich, Munich, Germany

Saad Shakir – Speaker

Director of the Drug Safety Research Unit

Drug Safety Research Unit, University of Portsmouth, Southampton, UK

Tim Steimle

Head of Medicines

Techniker Krankenkasse, Hamburg, Germany

Derek Stewart

Professor of Clinical Pharmacy and Practice

University of Qatar, Doha, Qatar

Dorothea Strobach

Head of Clinical Pharmacy Services

Ludwig Maximilian University of Munich, Munich, Germany

Samy Suissa – Speaker

Distinguished James McGill Professor of Epidemiology, Biostatistics and Medicine

McGill University, Montreal, QC, Canada

Cara Tannenbaum – Speaker

Scientific Director of the Canadian Institutes of Health Research

Canadian Institutes of Health Research, Ottawa, ON, Canada

Bart van den Bemt

Professor of Personalized Pharmaceutical Care

Radboud University, Nijmegen, The Netherlands

Anita Elaine Weidmann

Professor of Clinical Pharmacy

University of Innsbruck, Innsbruck, Austria